Media

Abattis Bioceuticals in the media includes articles, videos and education about our company and industry.

VIDEOS

COMFORT on Desert Living NBC
Naturopath Brazos Minshew discusses the benefits of plant-based medicine, how the stimulating the endocannabinoid system works and Vergence Natural's new proprietary product COMFORT on Desert Living NBC.
COMFORT on Colorado’s Best
Naturopath Brazos Minshew discusses the benefits of plant-based medicine, how pain affects us when we are overweight, over-tired or suffering from allergies, and Vergence Natural's new proprietary product COMFORT on Colorado's Best.
COMFORT on Atlanta Plugged In
Naturopath Brazos Minshew discusses the benefits of plant-based medicine, how pain affects us when we are overweight, over-tired or suffering from allergies, and Vergence Natural's new proprietary product COMFORT on Atlanta Plugged In.

ARTICLES

NEWS

Abattis Announces Successful Closing of Pi Nutrients
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.
Abattis Announces Successful Closing of Pro Natura Acquisition
May 21, 2019    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / May 21st, 2019 / Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2nd, 2019, the Company’s wholly-owned subsidiary, 1185277 B.C. Ltd. (the “Acquisition Subsidiary”) has successfully closed the acquisition (the “Acquisition”) of Pro Natura BV (“Pro Natura”).
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.
Abattis Provides Update on Trading Halt and Announces Management Conference Call
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.
Abattis Removed from BCSC Temporary Order
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.

BLOGS

ECS: Mind-Body Medicine
In the early 1600’s, a philosopher / mathematician named Rene Descartes first drew a line of distinction between the “mind”[...]
Linking the Known with the New
Plants have been used in medicine for thousands of years. Often, we knew that plants were effective, but we didn’t[...]
Abattis Medical Advisory Board Chairman Brazos Minshew spotlights Bisphenol A (BPA), a chemical linked to infertility and other health problems.
There is a simple way to describe your endocrine system: it is the glands and organs that make hormones. Hormones[...]
Abattis Medical Advisory Board Chairman Brazos Minshew, MSc, ND presents Thyroid Cancer Update in Austin, Texas USA
The Chairman of Abattis’ Medical Advisory Board presented an update to physicians on the explosive growth in thyroid cancer diagnosis[...]